More on NVAX
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Revenue | 102K |
| Research and development | 52.98M |
| General and administrative | 13.56M |
| Total operating expenses | |
| Loss from operations | -63.31M |
| Interest income | 554K |
| Interest expense | -3.51M |
| Change in fair value of warrant liability | |
| Loss from operations before income tax | |
| Income tax expense | |
| Net loss | -66.25M |
| Basic and diluted net loss per share | -0.24 |
| Basic and diluted weighted average number of common shares outstanding | |
Entities mentioned with NVAX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- Options | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
